Johnson & Johnson (JNJ) Offering Possible 6.84% Return Over the Next 28 Calendar Days

Johnson & Johnson’s most recent trend suggests a bullish bias. One trading opportunity on Johnson & Johnson is a Bull Put Spread using a strike $125.00 short put and a strike $115.00 long put offers a potential 6.84% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $125.00 by expiration. The full premium credit of $0.64 would be kept by the premium seller. The risk of $9.36 would be incurred if the stock dropped below the $115.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Johnson & Johnson is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Johnson & Johnson is bullish.

The RSI indicator is at 66.68 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Johnson & Johnson

New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock
Thu, 19 Jul 2018 01:12:17 +0000
Celgene (NASDAQ:CELG) continues to struggle. A series of self-inflicted wounds and a looming patent expiration plague the Summit, New Jersey-based firm. As a result, CELG stock has lost more than 40% of its value since its October 2017 high.

J&J’s Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod
Wed, 18 Jul 2018 21:57:09 +0000
The FDA approves Johnson and Johnson’s (JNJ) darunavir-based single-tablet regimen, Symtuza, for the treatment of type 1 HIV-1 in treatment-naive and certain virologically suppressed adults.

Healthcare ETFs in Focus Following JNJ Q2 Results
Wed, 18 Jul 2018 14:05:02 +0000
Investors should closely watch the movement of the Johnson & Johnson and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.

Penn, Johnson & Johnson team up to accelerate innovation
Wed, 18 Jul 2018 13:56:57 +0000
The university and health care giant are creating a life sciences network hub called JPOD@Philadelphia at the Pennovation Center.

Stock Market News For Jul 18, 2018
Wed, 18 Jul 2018 13:53:01 +0000
Markets closed sharply higher on Tuesday, led by a rally in tech stocks.

Be Sociable, Share!

Related Posts